COVID-19 Vaccine Booster Dose Willingness among Patients with Inflammatory Bowel Disease on Infliximab and Vedolizumab: A Cross-Sectional Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details